Archimed acquires majority stake in Brazilian wastewater treatment specialist Genetica
Wednesday, October 14, 2026 · first reported by PE Hub
Archimed acquires majority stake in Genetica, a Brazilian wastewater treatment and bio-based specialty products company. Genetica develops biological products for industrial wastewater, biogas generation, and crop protection.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on Archimed
Everything on this firm →- Blackstone inks $1.5bn sale of ZO Skin Health to GaldermaPE Hub
- LSEG Is in Discussions With Permira to Acquire Octus for About $3.5 BillionHedgeCo Insights
- Benefit Street bulks up ABF capabilities with Encina dealAlternative Credit Investor
- WCAS sells $2.8bn CenterWell clinic stake to BlackRock’s HPSPE Hub +1
- Rhône inks $900m Paragon Films sale to Atlantic Ridge and GrafinePE Hub +2
- Blackford Capital’s Habco acquires century-old Virginia electrical contractor EG MiddletonPE Hub